Core Laboratories
CLB
346 hedge funds and large institutions have $7.98B invested in Core Laboratories in 2014 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 141 increasing their positions, 117 reducing their positions, and 34 closing their positions.
21% more repeat investments, than reductions
Existing positions increased: 141 | Existing positions reduced: 117
18% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 34
6% more capital invested
Capital invested by funds: $7.51B → $7.98B (+$470M)
2.82% more ownership
Funds ownership: 86.63% → 89.45% (+2.8%)
0% more funds holding
Funds holding: 345 → 346 (+1)
0% more funds holding in top 10
Funds holding in top 10: 11 → 11 (0)
70% less call options, than puts
Call options by funds: $12.2M | Put options by funds: $40.8M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$75.3M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$42.7M |
| 3 |
Morgan Stanley
New York
|
+$37.5M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$23.4M |
| 5 |
BG
BlackRock Group
London,
United Kingdom
|
+$18.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$53.4M |
| 2 |
VAM
Vontobel Asset Management
New York
|
-$29.3M |
| 3 |
WI
WHV Investments
San Francisco,
California
|
-$25.1M |
| 4 |
SO
STRS Ohio
Columbus,
Ohio
|
-$22.9M |
| 5 |
ACM
Astenbeck Capital Management
Southport,
Connecticut
|
-$17.5M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RA
376
Royce & Associates
New York
| – | -$19K | -100 | Closed |
|
|
PCM
377
Prelude Capital Management
New York
| – | -$10K | -50 | Closed |
|
378
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$8K | -40 | Closed |
|
|
CFA
379
Camarda Financial Advisors
Fleming Island,
Florida
| – | -$5K | -25 | Closed |
|
380
Lazard Asset Management
New York
| – | -$1K | -7 | Closed |
|
CLB Hedge Fund Activity: Q1 2014 in Review
346 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q1 2014, worth a combined $7.98B — up 6.3% from $7.51B a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new CLB positions and 34 closed out — a net gain of 6 holders — while 141 added to existing stakes and 117 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $75.3M. The largest seller was Artisan Partners, cutting an estimated $53.4M.
- 346 institutional investors held Core Laboratories (CLB) as of Q1 2014, up from 345 in Q4 2013.
- Funds reported $7.98B of Core Laboratories stock for Q1 2014, up 6.3% quarter-over-quarter.
- 40 funds opened new Core Laboratories positions in Q1 2014 and 34 closed out, a net change of +6 holders.
- The largest Core Laboratories buyer in Q1 2014 was T. Rowe Price Associates, an estimated $75.3M added.
- The largest Core Laboratories seller in Q1 2014 was Artisan Partners, an estimated $53.4M sold.
Based on aggregated 13F filings for Q1 2014.